93 related articles for article (PubMed ID: 25802447)
21. [Genotype distribution of extended-spectrum beta-lactamases and AmpC beta-lactamases produced in Escherichia coli isolated from men with urinary infection].
Wang WP; Shao HF; Wang JN; Zhang XW; Shi LN
Zhonghua Nan Ke Xue; 2006 Nov; 12(11):1000-3. PubMed ID: 17146926
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic guidelines in the management of urinary tract infections and pyelonephritis.
Turck M
Urol Clin North Am; 1975 Oct; 2(3):443-50. PubMed ID: 1103409
[No Abstract] [Full Text] [Related]
23. Antibiotic resistance and pyelonephritis.
Foxman B; Ki M; Brown P
Clin Infect Dis; 2007 Aug; 45(3):281-3. PubMed ID: 17599304
[No Abstract] [Full Text] [Related]
24. Plasmid mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qep in ESBL-producing Escherichia coli clinical isolates from Egypt.
Hassan WM; Hashim A; Domany R
Indian J Med Microbiol; 2012; 30(4):442-7. PubMed ID: 23183470
[TBL] [Abstract][Full Text] [Related]
25. High rates of plasmid-mediated quinolone resistance QnrB variants among ciprofloxacin-resistant Escherichia coli and Klebsiella pneumoniae from urinary tract infections in Korea.
Shin JH; Jung HJ; Lee JY; Kim HR; Lee JN; Chang CL
Microb Drug Resist; 2008 Sep; 14(3):221-6. PubMed ID: 18707554
[TBL] [Abstract][Full Text] [Related]
26. Molecular detection of ESBLs production and antibiotic resistance patterns in Gram negative bacilli isolated from urinary tract infections.
Kargar M; Kargar M; Jahromi MZ; Najafi A; Ghorbani-Dalini S
Indian J Pathol Microbiol; 2014; 57(2):244-8. PubMed ID: 24943757
[TBL] [Abstract][Full Text] [Related]
27. Successful treatment of ctx-m ESBL producing Escherichia coli relapsing pyelonephritis with long term pivmecillinam.
Nicolle LE; Mulvey MR
Scand J Infect Dis; 2007; 39(8):748-9. PubMed ID: 17654359
[TBL] [Abstract][Full Text] [Related]
28. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817
[TBL] [Abstract][Full Text] [Related]
29. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
Oteo J; Orden B; Bautista V; Cuevas O; Arroyo M; Martínez-Ruiz R; Pérez-Vázquez M; Alcaraz M; García-Cobos S; Campos J
J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
[TBL] [Abstract][Full Text] [Related]
30. [Characterization of qnr gene for plasmid-mediated quionlone resistance].
Li CR; Lv X; Luo SF; Huang J
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Aug; 28(8):789-93. PubMed ID: 18080568
[TBL] [Abstract][Full Text] [Related]
31. [Investigation of plasmid-mediated quinolone resistance in Escherichia coli strains].
Aktepe OC; Aşık G; Cetinkol Y; Biçmen M; Gülay Z
Mikrobiyol Bul; 2012 Jan; 46(1):9-16. PubMed ID: 22399166
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and types of extended spectrum β-lactamases among urinary Escherichia coli isolates in Moroccan community.
Barguigua A; El Otmani F; Talmi M; Zerouali K; Timinouni M
Microb Pathog; 2013; 61-62():16-22. PubMed ID: 23643553
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and characteristics of β-lactamase and plasmid-mediated quinolone resistance genes in Escherichia coli isolated from farmed fish in China.
Jiang HX; Tang D; Liu YH; Zhang XH; Zeng ZL; Xu L; Hawkey PM
J Antimicrob Chemother; 2012 Oct; 67(10):2350-3. PubMed ID: 22809702
[TBL] [Abstract][Full Text] [Related]
34. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
[TBL] [Abstract][Full Text] [Related]
35. Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
Etienne M; Van Elslande H; Choplin-Renard J; Pestel-Caron M; Caron F
Med Mal Infect; 2014 May; 44(5):217-22. PubMed ID: 24787633
[TBL] [Abstract][Full Text] [Related]
36. Antibiotic therapy for acute uncomplicated pyelonephritis in women. Take resistance into account.
Prescrire Int; 2014 Dec; 23(155):296-300. PubMed ID: 25629148
[TBL] [Abstract][Full Text] [Related]
37. Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality.
Peña C; Gudiol C; Calatayud L; Tubau F; Domínguez MA; Pujol M; Ariza J; Gudiol F
J Hosp Infect; 2008 Feb; 68(2):116-22. PubMed ID: 18226420
[TBL] [Abstract][Full Text] [Related]
38. The prevalence of virulence genes of E. coli strains isolated from children with urinary tract infection.
Farshad S; Emamghorashi F
Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):613-7. PubMed ID: 19587502
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for quinolone-resistance in women presenting with Escherichia coli acute pyelonephritis.
Bedoin M; Cazorla C; Lucht F; Berthelot P; Boyer M; Carricajo A; Guérin T; Viallon A
Med Mal Infect; 2014 May; 44(5):206-16. PubMed ID: 24794820
[TBL] [Abstract][Full Text] [Related]
40. [Type 1 fimbriae, P fimbriae and X adhesins in Escherichia strains causing pyelonephritis, cystitis and recurrent urinary infections].
Andreu A; Xercavins M; Fernández F
Med Clin (Barc); 1989 Mar; 92(11):409-12. PubMed ID: 2566727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
